...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Selective and potent adenosine A3 receptor antagonists by methoxyaryl substitution on the N-(2,6-diarylpyrimidin-4-yl)acetamide scaffold
【24h】

Selective and potent adenosine A3 receptor antagonists by methoxyaryl substitution on the N-(2,6-diarylpyrimidin-4-yl)acetamide scaffold

机译:通过在N-(2,6-二芳基嘧啶-4-基)乙酰胺支架上进行甲氧基芳基取代来选择和有效的腺苷A3受体拮抗剂

获取原文
获取原文并翻译 | 示例
           

摘要

The influence of diverse methoxyphenyl substitution patterns on the N-(2,6-diarylpyrimidin-4-yl)acetamide scaffold is herein explored in order to modulate the A3 adenosine receptor antagonistic profile. As a result, novel ligands exhibiting excellent potency (Ki on A3 AR 20 nM) and selectivity profiles (above 100-fold within the adenosine receptors family) are reported. Moreover, our joint theoretical and experimental approach allows the identification of novel pharmacophoric elements conferring A3AR selectivity, first established by a robust computational model and thereafter characterizing the most salient features of the structure-activity and structure-selectivity relationships in this series.
机译:为了调节A3腺苷受体拮抗作用,本文探讨了各种甲氧基苯基取代方式对N-(2,6-二芳基嘧啶-4-基)乙酰胺支架的影响。结果,报道了显示出优异的效力(在A3AR上的Ki <20nM)和选择性概况(在腺苷受体家族内超过100倍)的新型配体。此外,我们的联合理论和实验方法允许鉴定赋予A3AR选择性的新型药效学元素,首先通过鲁棒的计算模型建立该模型,然后表征该系列中结构-活性和结构-选择性关系的最显着特征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号